BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23885696)

  • 1. New therapies in the treatment of overactive bladder.
    Yeo EK; Hashim H; Abrams P
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):319-37. PubMed ID: 23885696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
    Ellsworth P
    Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence in the treatment of overactive bladder.
    Brown ET; Martin L; Dmochowski RR
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):366-72. PubMed ID: 26308197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of overactive bladder syndrome.
    Srikrishna S; Robinson D; Cardozo L; Vella M
    Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the treatment of overactive bladder.
    Dmochowski RR; Gomelsky A
    Curr Opin Urol; 2011 Jul; 21(4):286-90. PubMed ID: 21499104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actual treatment of overactive bladder and urge urinary incontinence.
    Cornu JN
    Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacotherapy of overactive bladder.
    Athanasopoulos A
    Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical treatment of overactive bladder, including current and future treatments.
    Athanasopoulos A; Cruz F
    Expert Opin Pharmacother; 2011 May; 12(7):1041-55. PubMed ID: 21299469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for treatment of overactive bladder and detrusor overactivity.
    Drake MJ
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):431-46. PubMed ID: 18764721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview.
    Cipullo LM; Cosimato C; Filippelli A; Conti V; Izzo V; Zullo F; Guida M
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():27-34. PubMed ID: 24411952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of female overactive bladder syndrome and treatment-related effects.
    Hsiao SM; Lin HH
    J Formos Med Assoc; 2018 Oct; 117(10):871-878. PubMed ID: 29398096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding clinic options for overactive bladder.
    Bartley JM; Blum ES; Sirls LT; Peters KM
    Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder.
    Ellsworth P; Fantasia J
    Expert Opin Investig Drugs; 2015 Mar; 24(3):413-9. PubMed ID: 25557359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on the second line management of idiopathic overactive bladder].
    Chartier-Kastler E; Castro-Diaz D; De Ridder D; Everaert K; Sievert KD; Spinelli M; van Kerrebroeck P
    Prog Urol; 2009 Sep; 19(8):530-7. PubMed ID: 19699450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of refractory OAB in the non-neurogenic patient.
    Wadie BS
    Curr Urol Rep; 2014 Sep; 15(9):438. PubMed ID: 25015301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in the pharmacotherapy of the overactive bladder.
    Sellers DJ; McKay N
    Curr Opin Urol; 2007 Jul; 17(4):223-30. PubMed ID: 17558263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder.
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():8-13. PubMed ID: 21501545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxins.
    Apostolidis A
    Expert Opin Pharmacother; 2011 May; 12(7):1029-39. PubMed ID: 21288184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.